Advertisement
Supported by
Experts call for caution at Labor Day celebrations after cases have increased after other holidays in the US.But it’s not the first time Viral tests at home remain ambitious.Melbourne, Australia, prolonged its blockade for two weeks.
now i
Senator Kamala Harris, the Democratic vice presidential candidate, said she would only get a vaccine against the virus if medical experts said it’s safe.”I wouldn’t take your word for it, ” he said of the president.
Senator Kamala Harris of California, a Democratic vice presidential candidate, said she would not accept President Trump’s assurances that a coronavirus vaccine was safe and would wait for medical experts to verify that the vaccine was reliable before receiving an inoculation.
“I don’t take his word for it,” Harris said of Trump in CNN’s Inside Politics.
“He needs us to inject him with bleach,” he added, referring to comments in April when the president incomprehensibly recommended a harmful remedy for coronavirus.
Ms. Harris’s comments came after federal officials last week alerted state and major city public fitness agencies to prepare to distribute a vaccine to high-risk fitness personnel and other teams. from October or early November. Given that no vaccine candidate has completed the kind of large-scale human trials that can result in efficacy and safety, this delay has increased fears that the Trump administration will rush the launch of the vaccine before Election Day on November 3.
For months, Harris and Joseph R.Biden Jr. assaulted Trump for his pandemic management.Harris’ comments Sunday on the question of a possible vaccine, while scientists running for a vaccine report the constant strain of a White House concerned about smart news, are likely to sow skepticism among Americans about whether to get vaccinated when it becomes available.
With growing fears of the politicization of vaccines and treatments, five pharmaceutical corporations are preparing to factor this week and are pledging not to release a vaccine unless it meets strict criteria for efficacy and safety. Companies, Pfizer, Modern, Johnson
Harris also said Sunday that she and Biden would identify a national “standard” to dress in the mask without passing a court order.
“This is not a punishment. He is not an older brother,” Harris said, adding that dressing up in a mask is a “sacrifice” in times of crisis.
Her comments seemed to mark a softening of the position she and Biden had played in the past.
Last month, Biden and Harris asked Americans to wear masks, and told reporters after receiving a report from public fitness experts that each and every American wears an outdoor mask for at least 3 months and that all governors require the mask to be wearing.
In July, Biden warned that if he were president, he would require a mask to be used in public, and asked if he could use “federal influence to impose that,” he said it could be fair and “from the executive’s point of view.””
A look at all the vaccines that have come to human trials.
In recent weeks, a Harvard scientist has made headlines an ambitious concept aimed at reducing the spread of coronavirus: the deployment of antigenic tests, a technology outsider for decades, to tens of millions of Americans for nearly every day, in -Use at home.
These tests are not very smart to detect low-level infections, but they are reasonable and convenient, and give effects in minutes.Real-time information, argued by Dr. Michael Mina, a Harvard scientist, would be greater than the long delays blocking the line of evidence..
The immediate and common technique has attracted the attention of scientists and journalists from all over the world, as well as senior officials from the Department of Health and Human Services.
But more than a dozen experts said that almost ubiquitous antigen testing, though intriguing in theory, would possibly not be effective in practice.are increasingly disappointed by coronavirus testing.The purpose also assumes that immediate testing can achieve its purpose.
“We are open to the concept of deviating from the beaten track and finding new tactics for managing this pandemic,” said Esther Babady, director of clinical microbiology at Memorial Sloan Kettering Cancer Center in New York City, but said antigenic testing can simply bring the house paintings to market.
Moreover, no rigorous study has shown that common evidence is more delicate but slower in the genuine world, he said.”Knowledge for this is what is missing.”
What has been advanced on this technique is “largely ambitious, and we want to compare it to reality,” said Dr. Alexander McAdam, director of the Infectious Disease Diagnostic Laboratory at Boston Children’s Hospital and a recent report on a pandemic.Journal of Clinical Microbiology.
Most coronavirus tests to date are based on a laboratory strategy called PCR, long popular gold because it can detect even small amounts of genetic clothing from germs like coronavirus.
But chain-of-origin spraying has compromised efforts to collect, send, and process samples for PCR testing, lengthening response times.And the longer the wait, the lower the result.
Advertisement